Compile Data Set for Download or QSAR
Report error Found 417 Enz. Inhib. hit(s) with all data for entry = 6059
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106912BDBM106912(US8592455, 112)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106910BDBM106910(US8592455, 110)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106917BDBM106917(US8592455, 117)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106916BDBM106916(US8592455, 116)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106915BDBM106915(US8592455, 115)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106914BDBM106914(US8592455, 114)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106921BDBM106921(US8592455, 121)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106919BDBM106919(US8592455, 119)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106896BDBM106896(US8592455, 96)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106925BDBM106925(US8592455, 125)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106924BDBM106924(US8592455, 124)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106923BDBM106923(US8592455, 123)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106922BDBM106922(US8592455, 122)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106900BDBM106900(US8592455, 100)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106929BDBM106929(US8592455, 129)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106928BDBM106928(US8592455, 128)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106933BDBM106933(US8592455, 133)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106932BDBM106932(US8592455, 132)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106910BDBM106910(US8592455, 110)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106937BDBM106937(US8592455, 137)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106915BDBM106915(US8592455, 115)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106914BDBM106914(US8592455, 114)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106912BDBM106912(US8592455, 112)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106802BDBM106802(US8592455, 2)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106939BDBM106939(US8592455, 139)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106916BDBM106916(US8592455, 116)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106803BDBM106803(US8592455, 3)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106925BDBM106925(US8592455, 125)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106924BDBM106924(US8592455, 124)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106928BDBM106928(US8592455, 128)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106896BDBM106896(US8592455, 96)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106900BDBM106900(US8592455, 100)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106910BDBM106910(US8592455, 110)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106912BDBM106912(US8592455, 112)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106801BDBM106801(US8592455, 1)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106916BDBM106916(US8592455, 116)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106804BDBM106804(US8592455, 4)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106921BDBM106921(US8592455, 121)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106803BDBM106803(US8592455, 3)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106802BDBM106802(US8592455, 2)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106809BDBM106809(US8592455, 9)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106808BDBM106808(US8592455, 8)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106925BDBM106925(US8592455, 125)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106807BDBM106807(US8592455, 7)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106813BDBM106813(US8592455, 13)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106812BDBM106812(US8592455, 12)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106811BDBM106811(US8592455, 11)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106928BDBM106928(US8592455, 128)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106810BDBM106810(US8592455, 10)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 106817BDBM106817(US8592455, 17)
Affinity DataIC50: 1nMpH: 7.5Assay Description:The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

Displayed 1 to 50 (of 417 total ) | Next | Last >>
Jump to: